ArticleFrontiers in medicine2022

Comparison of hepatotoxicity of tegoprazan, a novel potassium-competitive acid blocker, with proton pump inhibitors using real-world data: A nationwide cohort study.

Min-Gul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.